South African scientists create Africa’s first gene-edited grapevine

The CRISPR-edited vine showed lower vulnerability to downy mildew and stronger water-conservation traits in early research

2026-07-15

Scientists at Stellenbosch University and South Africa’s Agricultural Research Council have developed what Nature Biotechnology described as Africa’s first gene-edited grapevine, using CRISPR-Cas9 to reduce the plant’s vulnerability to downy mildew and improve its ability to conserve water.

The report was published Tuesday in Nature Biotechnology as part of its “Biotech news from around the world” roundup. According to the journal, the researchers silenced a grapevine gene known as VvDMR6.1. That change made the edited vine less susceptible to downy mildew, a destructive disease that affects vineyards worldwide, and also strengthened traits linked to water retention.

The combination is notable because it addresses two pressures at once: disease and drought stress. Downy mildew can cause major crop losses and often requires repeated fungicide treatments. Water stress, meanwhile, has become a growing concern for wine regions facing hotter conditions and more erratic rainfall.

Nature Biotechnology said the edited plants showed lower vulnerability to the fungal disease while also increasing their capacity to conserve water, suggesting a broader defensive effect against both biological threats and environmental strain. The brief item did not provide detailed field performance data in the excerpt available publicly, and it did not say whether the vines have moved beyond research stages into commercial evaluation.

Even so, the development points to a direction that many grape growers and wine producers are watching closely. If similar results hold up in further testing and pass regulatory review, gene-edited vines could help vineyards reduce losses from mildew, lower dependence on crop protection sprays and manage water more efficiently in dry years. For the beverage sector, that could eventually matter in both farming costs and supply stability, especially in wine production where grape quality and vineyard resilience are closely tied.

The announcement also places African research institutions more visibly in the global race to apply gene editing to crops with commercial value. Grapevines are among the most economically important fruit crops in agriculture, but they are also difficult breeding targets because traditional improvement can take years and may alter traits valued by growers and winemakers. Gene editing has drawn attention because it can target specific genes without requiring long conventional breeding cycles.

The same Nature Biotechnology roundup also highlighted a separate genomics milestone from India. The GenomeIndia sequencing project identified 130 million genetic variants across the population, nearly one-third of them previously unreported in global scientific databases. Funded by India’s Department of Biotechnology, the project analyzed the genomes of 9,768 healthy people from 83 populations.

According to the journal, that dataset revealed genetic risk factors in some populations, including variants that affect how the body processes certain drugs, variants linked to anesthesia-related complications and high levels of genetic homozygosity, which can increase the risk of recessive genetic diseases.

While that Indian project is unrelated to viticulture, both items reflect how biotechnology research is expanding beyond its traditional centers and moving into practical questions of health, agriculture and food production. In the case of the South African grapevine work, the immediate significance lies in whether gene editing can help vineyards respond to climate pressure and persistent disease without sacrificing agronomic performance.

Questions remain about regulation, consumer acceptance and how edited vines would be classified in different export markets. Those issues are especially important for wine, where appellation rules, nursery systems and international trade standards can shape adoption as much as science does. But the South African result adds new evidence that targeted gene editing is being explored not only for yield or laboratory proof of concept, but also for traits that could affect how vineyards cope with disease pressure and limited water.